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Public health surveillance systems are fundamental to 
the prevention and control of infectious diseases. Data 
obtained by sentinel surveillance systems may be used to 
inform public health decision making, priority setting and 
subsequent action.1 
Seasonal influenza epidemics are a major public health concern 
globally, resulting in millions of respiratory illnesses and 
250 000–500 000 deaths worldwide each year.2 In Australia, several 
surveillance systems report on influenza epidemiology on a national 
and jurisdictional level. The Australian Sentinel Practices Research 
Network (ASPREN) is a clinically based general practitioner sentinel 
surveillance system that employs the nationally adopted case 
definition for influenza-like illness (ILI) of fever, cough and fatigue.3 
Sentinel practice surveillance systems aim to monitor influenza activity 
in the community by providing timely and geographic information 
about seasonal viruses.
 Other established Australian influenza surveillance systems currently 
consist of laboratory confirmed cases of influenza; three jurisdictional GP 
sentinel practice systems in Western Australia, Victoria and Northern 
Territory; and emergency department hospital admissions. Alternative 
methods of tracking influenza include telephone surveys4,5 and internet 
based systems.6–9 FluTracking is an online self reporting system that 
records influenza-like symptoms and vaccination status. The National 
Notifiable Diseases Surveillance System (NNDSS) reports laboratory 
notifications of influenza. Both ASPREN and FluTracking track influenza-
like symptoms, while NNDSS influenza notifications are a measure 
of true influenza in the population. It is accepted that a combined 
surveillance approach has the greatest value.10–14 
 The objectives of this study were to compare the reported 
incidence of ILI recorded by ASPREN and FluTracking in two influenza 
seasons (2007–2008), and to compare timing and concordance of 
Background
General practitioners play an important role in the detection and 
clinical management of influenza. The Australian Sentinel Practice 
Research Network (ASPREN) has been collecting data from sentinel 
GPs on selected conditions, including influenza-like illness (ILI), 
since 1991 to inform public health authorities of communicable 
disease activity in the community.
Methods
Weekly incidence of ILI data reported by ASPREN GPs in 2007–2008 
was compared with data from two separate surveillance systems: 
New South Wales data from FluTracking, an online self reporting 
ILI surveillance system; and national laboratory notifications of 
influenza reported to the National Notifiable Diseases Surveillance 
System between 2003 and 2008.
Results
ASPREN recorded peak ILI rates of 47 per 1000 consultations in 
week 30 (ending 29 July) 2007 and 34 per 1000 consultations in week 
36 (ending 7 September) 2008. Similar trends in incidence were 
seen in FluTracking cough and fever rates, ASPREN data in New 
South Wales and National Notifiable Diseases Surveillance System 
laboratory notifications.
Discussion
Data captured by the three separate surveillance systems provide 
complementary information regarding influenza in the Australian 
population.
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could participate (11.9% of participants in that year). No information on 
gender is collected by FluTracking. Substantially elevated rates of cough 
and fever in unvaccinated participants compared to influenza vaccinated 
participants are interpreted as indicating increased influenza infection. 
Of participants across NSW, 77% (578/748) and 66% (1765/2689) were 
resident in postcodes in the Hunter New England Area Health Service 
region in 2007 and 2008 respectively.  
 The NNDSS was established in 1990 under the auspices of 
the Communicable Diseases Network Australia.16 The system 
coordinates the national surveillance of over 60 communicable 
diseases, including laboratory confirmed cases of influenza. 
Notifications of laboratory confirmed influenza are reported to the 
NNDSS by jurisdictional health authorities. Sources of notifications 
include both public and private laboratories, and hospitals and 
doctors. The NNDSS notifications may include hospital and general 
practice patients and other groups such as those tested as a result of 
disease outbreaks.
 For this study we have defined the NNDSS peak notification as 
the week with the highest number of laboratory confirmed influenza 
notifications.
 In 2007, an average of 21 GPs from NSW reported ILI rates 
each week to ASPREN; in 2008, it was 19. These rates were then 
compared to weekly rates of cough and fever reported by 748 and 
2689 FluTracking participants in 2007 and 2008 respectively. National 
influenza notification totals reported to NNDSS were compared to 
ASPREN ILI rates over the 5 year period from 2003–2008. 
Results
ASPREN 2007–2008 
An average of 67 doctors across the seven states and territories 
reported to ASPREN each week in 2007 for a total of 6118 notifications 
for ILI. In 2008, 80 doctors reported for a total of 4215 notifications. The 
peak reported ILI rate was 47 per 1000 consultations in week 30 (ending 
29 July) in 2007 and 34 per 1000 in week 36 (ending 7 September) in 
2008 (Table 1). Across jurisdictions there was greater variation in the 
ASPREN reported ILI with laboratory confirmed influenza reported by 
NNDSS between 2003 and 2008.
Methods
The ASPREN project was formed in 1991 to provide a rapid 
monitoring system for infectious diseases that can warn public health 
officials of epidemics in their early stages, inform public health 
campaigns, and facilitate research of conditions commonly seen 
in general practice. Owned and operated by The Royal Australian 
College of General Practitioners (RACGP), ASPREN is directed through 
the Discipline of General Practice at the University of Adelaide in 
South Australia. Influenza-like illness data collected by ASPREN is 
routinely used by national and state and territory health departments 
for influenza surveillance and research. Participating GPs receive 
continuing medical education points via the RACGP and/or the 
Australian College of Rural and Remote Medicine.
 The ASPREN conducts online ILI surveillance across seven states 
and territories. A total of 102 GPs currently report to ASPREN, with 
64%, 22% and 14% reporting from metropolitan, rural and remote 
areas respectively. Participating GPs enter the age and gender data 
of persons presenting with an ILI (defined as cough, fever and fatigue) 
into the ASPREN database, along with weekly consultation totals via 
a web based notification system. Weekly incidences of ILI per 1000 
consultations during 2007 and 2008 were calculated from this data. 
The week with the highest ILI incidence rate in a year was designated 
the ILI peak week.
 The online FluTracking survey allows participants to record their 
past and current influenza immunisation status; a weekly email prompt 
asks participants to answer questions regarding the previous week’s 
experience of cough, fever and time absent from normal activities.15 
Rates of cough and fever among FluTracking participants are compared 
by influenza vaccination status. FluTracking participants are recruited 
through email invitations circulated by government and corporate 
email systems, invitations forwarded by participants to friends, media 
releases directing prospective participants to the Flutracking.net website 
and directly through the website. FluTracking is a joint project of the 
University of Newcastle and Hunter New England Health. Participants 
from all Australian jurisdictions are involved in FluTracking; however 
in 2008, 56% of participants were from New South Wales (NSW) 
– the focus of the comparison with ASPREN. In 2007, participants 
less than 18 years of age were not eligible to participate, and only 
4.1% of participants were aged 65 years or more. Of participants who 
responded to at least one survey in 2008, 78.4% were aged 25–65 
years. 2008 was the first year that persons aged less than 18 years 
Table1. ASPREN peak ILI consultation rates 2007–2008
State
Peak iLi incidence per 1000 
consultations (95% Ci)
Week of peak
2007 2008 2007 2008
ACT  79 (63, 98)  57 (44, 74) 32 39
NSW  73  (58, 92)  61 (47, 78) 32 36
QLD  40  (29, 55)  47 (35, 63) 31 31
TAS  NA  28 (19, 41) NA 34
VIC  34  (24, 48)  27 (19, 39) 32 and 33 37
SA  48  (36, 64)  24 (16, 36) 33 37
WA  56  (43, 73)  30 (21, 43) 28 36
All states/
territories*
 47  (42.7, 51.8)  34 (30.8, 38.7) 30 36
* No ASPREN GPs report from the Northern Territory
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 The onset of the season occurred later in 2008 than in 2007 
(Figure 1). Baseline ILI rates reported between January and July 
2008, before the influenza season, were approximately half compared 
to the same period in 2007. The mean ILI incidence was 15.96 per 
1000 consultations in 2007 (95% CI: 15.29–16.66) compared to 
7.67 (95% CI: 7.30–8.06) in 2008 (p=<.0001). During the season ILI 
rates remained at higher levels for approximately 8 weeks in 2007 
compared to 6 weeks in 2008. The highest proportion of ASPREN ILI 
cases occurred in patients aged 20–49 years (43% in 2007 and 44% 
in 2008), followed by patients aged 5–19 years (20% and 21%). 
ASPREN compared to Flutracking 2007–2008
In 2007, the weekly incidence of cough and fever in NSW peaked 
among unvaccinated FluTracking participants in week 31 (ending 5 
August) at 14.5%, 1 week before the peak ASPREN ILI rate for NSW 
(Figure 2). In week 32 (ending 12 August), ASPREN recorded a peak 
ILI incidence in NSW of 73 per 1000 consultations – 1 week after 
FluTracking.
 The first indication of elevated influenza activity in FluTracking 
appeared in week 26 (ending 1 July) with a divergence in cough and 
fever rates between unvaccinated and vaccinated participants for 2 
weeks. The next major divergences occurred in week 30 (ending 29 
July) and week 33 (ending 19 August). These divergences coincide 
with the increase in ILI reported by ASPREN GPs. 
In 2008, the weekly incidence of cough and fever peaked among 
unvaccinated participants in week 35 (ending 31 August) 2008 at 
6.8%, less than half the peak rate in 2007. A peak ILI incidence of 
61 cases per 1000 consultations was recorded in NSW by ASPREN 2 
weeks later in week 37 (ending 14 September).
 The divergence between unvaccinated FluTracking participants 
and vaccinated participants in weeks 20 and 24 (ending 8 May and 
15 June) correlate with isolated peaks in ASPREN consultations. Both 
ASPREN and FluTracking recorded an upswing in rates from week 
31 (ending 3 August). The rise continued in both systems to week 35 
(ending 31 August), when the FluTracking peak was observed. 
ASPREN compared to NNDSS 2003–2008
Figure 3 presents a comparison of ASPREN ILI rates with the total 
number of laboratory confirmed cases of influenza reported by the 
NNDSS from 2003–2008. In each year, both initial increases in ILI and 
the peak rates reported by ASPREN occurred before increases and 
peaks in laboratory notifications being observed. 
Discussion
The three surveillances systems presented in this study capture 
different sources of data for ILI and influenza: clinical cases of 
ILI diagnosed by GPs (ASPREN), online self reports of community 
recruited participants' influenza symptoms (FluTracking) and national 
laboratory confirmed notifications of influenza (NNDSS). 
 The comparison between increases in ILI rates recorded by 
ASPREN GPs in NSW and rates of cough and fever in unvaccinated 
occurrence of the peak ILI week between years: in 2007, it was weeks 
28–32 (weeks ending 15 July to 12 August); in 2008, it was weeks 
31–39 (weeks ending 3 August to 28 September).
Source: Department of Health and Ageing. National Notifiable Diseases 
Surveillance System, 2009
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Figure 1. ILI rate per 1000 consultations reported to ASPREN 2007–2008
Source: Department of Health and Ageing. National Notifiable Diseases 
Surveillance System, 2009
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Figure 2. ASPREN vs. FluTracking in NSW June to October 2007, May to October 2008
Source: Department of Health and Ageing. National Notifiable Diseases 
Surveillance System, 2009
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Figure 3. ASPREN vs. NNDSS notifications 2003–2008
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 FluTracking participants are primarily located in NSW, with 
participants in NSW concentrated within the Hunter New England 
area. FluTracking is in the early phase of its implementation and 
interpretation of the data is based on only two seasons of influenza. 
As FluTracking usually operates between May and October, the 
onset of influenza may be missed outside this surveillance period. 
Additionally, while FluTracking has the ability to discriminate 
influenza infection based upon the vaccination status of the 
participants, a mismatch between the vaccine and the circulating 
influenza strain would prevent the typical divergence in influenza-
like symptoms observed between vaccinated and unvaccinated 
participants. However, the failure of this divergence accompanied 
by ILI increases in ASPREN and increases in laboratory confirmed 
influenza could give an early warning of vaccine failure. 
 Despite these limitations, ASPREN’s results, when compared 
to influenza laboratory confirmed by NNDSS, demonstrate that it 
is consistently detecting both temporal and seasonal changes in 
influenza incidence. 
implications for general practice
•	 	Online	 technologies	 to	 predict	 influenza	outbreaks	are	beneficial	
in their potential to capture information on large numbers of 
people.6,9,22–23 Information provided by these media is useful 
when it is compared with other clinical systems that detect 
increased activity in the community. 
•	 	General	practitioners	play	a	critical	role	in	diagnosing	and	managing	
influenza and potential complications in high risk groups; they also 
have a critical role in responding to public health alerts in the event 
of an epidemic or pandemic.24,25 
•	 	The	 use	 of	 online	 technology	 by	 current	 ASPREN	 reporters	
requires individual GPs to enter data. The potential to capture 
a higher volume of data may exist in the application of evolving 
practice software to automatically extract relevant coded data. 
Resource 
Fortnightly data reports are available from the ASPREN website at www.
dmac.adelaide.edu.au/aspren.
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